From the Stroke Research Center (N.R., A.C., D.R., M.O., M.E.G., J.R., S.M.G., J.N.G., A.V.), Department of Neurology, Division of Neurocritical Care and Emergency Neurology (J.R., J.N.G.), Center for Genomic Medicine (J.R.), and Henry and Allison McCance Center for Brain Health (J.R.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (N.R.), Hôpital Pierre-Paul Riquet, Centre Hospitalier Universitaire de Toulouse; Toulouse NeuroImaging Center (N.R.), Université de Toulouse, Inserm, UPS, France; and Division of Neurology (D.R.), Faculty of Medicine, Department of Medicine, Naresuan University, Phitsanulok, Thailand.
Neurology. 2020 Mar 3;94(9):e968-e977. doi: 10.1212/WNL.0000000000009036. Epub 2020 Feb 4.
To investigate whether acute convexity subarachnoid hemorrhage (cSAH) associated with acute lobar intracerebral hemorrhage (ICH) increases the risk of ICH recurrence in patients with cerebral amyloid angiopathy (CAA).
We analyzed data from a prospective cohort of consecutive survivors of acute spontaneous lobar ICH fulfilling the Boston criteria for possible or probable CAA (CAA-ICH). We analyzed baseline clinical and MRI data, including cSAH (categorized as adjacent or remote from ICH on a standardized scale), cortical superficial siderosis (cSS), and other CAA MRI markers. Multivariable Cox regression models were used to assess the association between cSAH and recurrent symptomatic ICH during follow-up.
We included 261 CAA-ICH survivors (mean age 76.2 ± 8.7 years). Of them, 166 (63.6%, 95% confidence interval [CI] 57.7%-69.5%) had cSAH on baseline MRI. During a median follow-up of 28.3 (interquartile range 7.2-57.0) months, 54 (20.7%) patients experienced a recurrent lobar ICH. In Cox regression, any cSAH, adjacent cSAH, and remote cSAH were independent predictors of recurrent ICH after adjustment for other confounders, including cSS. Incidence rate of recurrent ICH in patients with cSAH was 9.9 per 100 person-years (95% CI 7.3-13.0) compared with 1.2 per 100 person-years (95% CI 0.3-3.2) in those without cSAH (adjusted hazard ratio 7.5, 95% CI 2.6-21.1).
In patients with CAA-related acute ICH, cSAH (adjacent or remote from lobar ICH) is commonly observed and heralds an increased risk of recurrent ICH. cSAH may help stratify bleeding risk and should be assessed along with cSS for prognosis and clinical management.
研究急性脑凸面蛛网膜下腔出血(cSAH)是否会增加脑淀粉样血管病(CAA)患者并发的急性脑叶脑出血(ICH)的再出血风险。
我们分析了满足波士顿可能或可能的 CAA(CAA-ICH)标准的急性自发性脑叶 ICH 连续幸存者的前瞻性队列研究数据。我们分析了基线临床和 MRI 数据,包括 cSAH(根据标准化量表分类为与 ICH 相邻或远离)、皮质浅表铁质沉着症(cSS)和其他 CAA MRI 标志物。使用多变量 Cox 回归模型评估 cSAH 与随访期间复发性症状性 ICH 之间的关系。
我们纳入了 261 例 CAA-ICH 幸存者(平均年龄 76.2±8.7 岁)。其中,166 例(63.6%,95%置信区间[CI]57.7%-69.5%)在基线 MRI 上有 cSAH。在中位数为 28.3(四分位距 7.2-57.0)个月的随访期间,54 例(20.7%)患者发生了复发性脑叶 ICH。在 Cox 回归中,任何 cSAH、相邻 cSAH 和远处 cSAH 在调整了其他混杂因素(包括 cSS)后,都是复发性 ICH 的独立预测因素。cSAH 患者的复发性 ICH 发生率为 9.9 例/100 人年(95%CI7.3-13.0),而无 cSAH 患者为 1.2 例/100 人年(95%CI0.3-3.2)(调整后的危险比 7.5,95%CI2.6-21.1)。
在 CAA 相关的急性 ICH 患者中,常见的是 cSAH(与脑叶 ICH 相邻或远离),预示着再出血的风险增加。cSAH 可能有助于分层出血风险,应与 cSS 一起评估,以预测和临床管理。